Profile image
By GMO Pundit (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Iarc Monographs Evaluate Hazard, Not Risk.

Wednesday, April 19, 2017 13:17
% of readers think this story is Fact. Add your two cents.

(Before It's News)

IARC’s work is focused exclusively on assessing the cancer hazard of a substance or action. It does not evaluate or determine cancer risk. This distinction often confuses the public because IARC uses the word “risk” in its monograph titles,[2] but its monographs preamble states the actual aim is to “identify cancer hazards even when risks are very low at current exposure levels.”[3]

This distinction makes a difference. An activity or exposure is considered a cancer hazard if it can potentially cause cancer under some possible set of circumstances. However, the activity or exposure also must be evaluated based on the cancer risk it poses to determine how likely it is that exposure to a substance or action will cause harm.

Unlike a simple hazard analysis, a risk assessment takes into account factors such as dose/concentration, exposure pathways, and probability of exposure to determine the likelihood that any given hazard will actually cause harm. Therefore, evaluations of cancer risks are far more relevant to policymakers and the public than IARC-reviewed cancer hazards…

IARC – Campaign for Accuracy in Public Health Research:



Source: http://gmopundit.blogspot.com/2017/04/iarc-monographs-evaluate-hazard-not-risk.html

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.